Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Postema

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
BMC Urology|April 7, 2017
The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patientsA W Postema, M J V Scheltema, C K Mannaerts, et al.
The Journal of Urology|June 28, 2019
Multiparametric Ultrasound for Prostate Cancer Detection and Localization: Correlation of B-mode, Shear Wave Elastography and Contrast Enhanced Ultrasound with Radical Prostatectomy SpecimensChristophe K Mannaerts, Rogier R Wildeboer, Sebastiaan Remmers, et al.
BJUI Compass|February 6, 2026
Omission of contralateral biopsies in unilateral MRI-suspicious prostate cancer has minimal impact on clinical risk assessmentStijn M van den Bosch, Daniël L van den Kroonenberg, Bram W van Bruggen, et al.
Cancers|July 13, 2024
Is There an Added Value of Quantitative DCE-MRI by Magnetic Resonance Dispersion Imaging for Prostate Cancer Diagnosis?Auke Jager, Jorg R Oddens, Arnoud W Postema, et al.
European Urology Open Science|April 1, 2024
The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Magnetic Resonance Imaging Undergoing Robot-assisted Radical Prostatectomy for Prostate CancerDaniël L van den Kroonenberg, Joëlle D Stoter, Auke Jager, et al.
BJU International|April 22, 2020
Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsyChristophe K Mannaerts, Marc R W Engelbrecht, Arnoud W Postema, et al.
European Urology Open Science|January 19, 2026
Real-world Inter-rater Agreement of PI-QUAL Version 2 for Prostate Magnetic Resonance Imaging Quality Assessment and Its Association with Diagnostic AccuracyDaniel L van den Kroonenberg, Jelle Barentsz, Bo J Hamstra, et al.
World Journal of Urology|February 21, 2020
Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimensArnoud W Postema, Maudy C W Gayet, Ruud J G van Sloun, et al.
European Radiology|November 6, 2025
Evaluation of an artificial intelligence model based on multiparametric transrectal ultrasound for localizing clinically significant prostate cancer by simulation of targeted biopsiesDaniel L van den Kroonenberg, Florian Delberghe, Auke Jager, et al.
The Journal of Urology|March 24, 2016
Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect StudyW van den Bos, R R Jurhill, D M de Bruin, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
BMC Urology|April 7, 2017
The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patientsA W Postema, M J V Scheltema, C K Mannaerts, et al.
The Journal of Urology|June 28, 2019
Multiparametric Ultrasound for Prostate Cancer Detection and Localization: Correlation of B-mode, Shear Wave Elastography and Contrast Enhanced Ultrasound with Radical Prostatectomy SpecimensChristophe K Mannaerts, Rogier R Wildeboer, Sebastiaan Remmers, et al.
BJUI Compass|February 6, 2026
Omission of contralateral biopsies in unilateral MRI-suspicious prostate cancer has minimal impact on clinical risk assessmentStijn M van den Bosch, Daniël L van den Kroonenberg, Bram W van Bruggen, et al.
Cancers|July 13, 2024
Is There an Added Value of Quantitative DCE-MRI by Magnetic Resonance Dispersion Imaging for Prostate Cancer Diagnosis?Auke Jager, Jorg R Oddens, Arnoud W Postema, et al.
European Urology Open Science|April 1, 2024
The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Magnetic Resonance Imaging Undergoing Robot-assisted Radical Prostatectomy for Prostate CancerDaniël L van den Kroonenberg, Joëlle D Stoter, Auke Jager, et al.
BJU International|April 22, 2020
Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsyChristophe K Mannaerts, Marc R W Engelbrecht, Arnoud W Postema, et al.
European Urology Open Science|January 19, 2026
Real-world Inter-rater Agreement of PI-QUAL Version 2 for Prostate Magnetic Resonance Imaging Quality Assessment and Its Association with Diagnostic AccuracyDaniel L van den Kroonenberg, Jelle Barentsz, Bo J Hamstra, et al.
World Journal of Urology|February 21, 2020
Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimensArnoud W Postema, Maudy C W Gayet, Ruud J G van Sloun, et al.
European Radiology|November 6, 2025
Evaluation of an artificial intelligence model based on multiparametric transrectal ultrasound for localizing clinically significant prostate cancer by simulation of targeted biopsiesDaniel L van den Kroonenberg, Florian Delberghe, Auke Jager, et al.
The Journal of Urology|March 24, 2016
Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect StudyW van den Bos, R R Jurhill, D M de Bruin, et al.
Pageof 5